Zhongxin Finance, February 17. According to the news from Shanghai Sunshine Pharmaceutical Purchasing Network on the 17th, the Joint Purchasing Office will start the seventh batch of state-organized centralized drug procurement related drug information reporting from February 18.
The scope of this report involves a total of 208 product specifications, including oseltamivir oral normal-release dosage form, afatinib oral normal-release dosage form, memantine hydrochloride sustained-release capsules, octreotide injection, etc. Common and life-saving drugs for many diseases such as Zheimer's disease.
(Finish)